Liver tumors were induced in mice of A/Jax strain after a single, subcutaneous injection of 0.4 or 0.7mg of
o-aminoazotoluene within 24 hours after birth. Among 26 treated males, 12 males (46.2%) developed liver tumor during the observation period of 15 months, whereas, among 27 females, only 5 females (18.5%) developed tumors, a significant sex difference being observed. This is quite contrary to the incidence of liver tumors in the male and female of A/Jax strain mice that received monthly injections of the same azo dye starting at young adult age. Partial hepatectomy performed at 6 months of age augmented liver tumor development after neonatal injection of
o-aminoazotoluene. In both males and females, hepatic lesions demonstrated by histologic observation occurred as early as 24 hours after the injection, and reached the maximum on the 20th day. These hepatic lesions were repaired almost completely within a few weeks. However, the liver of mice exposed to
o-aminoazotoluene at birth still showed histological alteration, i.e., variation of cell size, which might persist throughout the observation period. It seemed that such hepatic alteration was more prominent in the male than in the female. The possible significance of hepatic changes induced by
o-aminoazotoluene injection on sex difference in the incidence of liver tumors is briefly discussed.
It was also observed that neonatal injection of
o-aminoazotoluene resulted in a fairly high incidence of pulmonary adenomas, and a slight, but probably significant, increase in leukemia incidence.
View full abstract